Equity Capital Markets

Company · CIK 1750019

TCR2 THERAPEUTICS INC.

CIK1750019 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
Listedno ticker on SEC record today
First annual or quarterly report2019-03-29

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-236965
ShelfEffective
 2020-03-062023-06-057
333-254355
ShelfEffective
 2021-03-162023-06-054
333-229066
IPOFinal prospectus
 2018-12-282019-02-155

Filings

18
FiledFilingRegistrationAccession
2023-06-05EFFECTDeclared effective 333-2543559999999995-23-001627
2023-06-05EFFECTDeclared effective 333-2522449999999995-23-001626
2023-06-05EFFECTDeclared effective 333-2369659999999995-23-001625
2022-03-23EFFECTDeclared effective 333-2543559999999995-22-000698
2021-04-30424B5Shelf takedown 333-2543550001193125-21-145133
2021-03-16S-3ASRShelf registered 333-2543550001193125-21-082946
2021-01-21424B5Shelf takedown 333-2369650001193125-21-012567
2021-01-19424B5Shelf takedown 333-2369650001193125-21-010752
2020-07-29424B5Shelf takedown 333-2369650001193125-20-202547
2020-07-27424B5Shelf takedown 333-2369650001193125-20-199694
2020-04-28EFFECTDeclared effective 333-2369659999999995-20-000897
2020-03-06S-3Shelf registered 333-2369650001193125-20-065218
2019-02-15424B4Final prospectus 333-2290660001193125-19-042430
2019-02-13EFFECTDeclared effective 333-2290669999999995-19-000215
2019-02-13S-1/AAmendment 333-2290660001193125-19-037835
2019-02-01S-1/AAmendment 333-2290660001193125-19-025782
2018-12-28S-1Registration filed 333-2290660001193125-18-360714
2018-09-07DRSDraft made public 377-022540000950123-18-009342

All filings of this company · CSV